Reported risk factors for DAOSD include more severe baseline atopic disease, previous history of conjunctivitis, facial or eyelid eczema, and elevated baseline serum biomarkers (thymus and activation-regulated chemokine [TARC], eosinophils, and immunoglobulin E [IgE]) [3,6,10]. This evidence concerns the gene CCL17 and conjunctivitis.